WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options

CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options

Raccontata da

morningstar.com

independent.co.uk

fiercepharma.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo13 h fa

CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage…

CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options

Timeline cronologica

giovedì 28 maggio 2026·morningstar.com
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
giovedì 28 maggio 2026·cnbc.com
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

independent.co.uk

8 h fa

CVS expands access to blockbuster weight-drugs in surprise reversal

This move marks a pivotal shift for patients seeking access to these highly sought-after treatments

Leggi questa versione → originale

fiercepharma.com8 h fa

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will

Leggi questa versione → originale

cnbc.com13 h fa

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

Leggi questa versione → originale

giovedì 28 maggio 2026·

independent.co.uk

CVS expands access to blockbuster weight-drugs in surprise reversal

This move marks a pivotal shift for patients seeking access to these highly sought-after treatments

giovedì 28 maggio 2026·

fiercepharma.com

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will